Rare diseases
Investigational molecules
Locations
Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis
GermanyStudy on Nintedanib for Adults with Unicentric Castleman Disease
FranceLong-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel
SpainStudy on the Effects of Wharton's Jelly Mesenchymal Stem Cells, Pirfenidone, and Nintedanib for Patients with Fibrotic Interstitial Lung Disease
PolandStudy of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis
BelgiumEffect of BI 1015550 on blood levels of nintedanib and pirfenidone in healthy men
GermanyStudy on the Effectiveness of Nintedanib for Treating Nosebleeds in Patients with Hereditary Hemorrhagic Telangiectasia
FranceStudy on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease
BelgiumStudy on Idiopathic Pulmonary Fibrosis: Evaluating Pirfenidone and Nintedanib for Patients with Progressive Disease
FranceStudy on the Effectiveness of Nintedanib and Tocilizumab for Patients with Systemic Sclerosis and Interstitial Lung Disease
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
